GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $203,477 | -23.4% | 72,155 | +10.5% | 0.00% | – |
| Q1 2024 | $265,710 | +146.7% | 65,285 | 0.0% | 0.00% | – |
| Q4 2023 | $107,720 | -59.9% | 65,285 | -7.8% | 0.00% | – |
| Q3 2023 | $268,431 | -30.1% | 70,826 | +1.4% | 0.00% | – |
| Q2 2023 | $383,988 | +60.0% | 69,816 | +25.1% | 0.00% | – |
| Q1 2023 | $239,966 | +7.3% | 55,806 | -1.9% | 0.00% | – |
| Q4 2022 | $223,641 | -20.4% | 56,906 | +7.4% | 0.00% | – |
| Q3 2022 | $281,000 | -14.6% | 53,006 | +5.8% | 0.00% | – |
| Q2 2022 | $329,000 | -2.7% | 50,106 | +8.7% | 0.00% | – |
| Q1 2022 | $338,000 | +3.7% | 46,106 | +0.2% | 0.00% | – |
| Q4 2021 | $326,000 | -71.7% | 46,006 | 0.0% | 0.00% | – |
| Q3 2021 | $1,153,000 | -6.9% | 46,006 | 0.0% | 0.00% | – |
| Q2 2021 | $1,238,000 | -5.4% | 46,006 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $1,309,000 | – | 46,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penn Mutual Asset Management | 73,065 | $1,965,000 | 2.46% |
| Artal Group S.A. | 2,814,191 | $75,702,000 | 1.54% |
| Yiheng Capital Management, L.P. | 1,416,483 | $38,103,000 | 1.53% |
| Casdin Capital, LLC | 1,611,214 | $43,342,000 | 1.10% |
| HARVARD MANAGEMENT CO INC | 512,349 | $13,782,000 | 0.79% |
| Bellevue Group AG | 2,478,180 | $66,664,000 | 0.65% |
| AWM Investment Company, Inc. | 225,599 | $6,069,000 | 0.60% |
| Carmignac Gestion | 1,473,524 | $39,637,000 | 0.46% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $94,150,000 | 0.38% |
| Darwin Global Management, Ltd. | 10,738 | $289,000 | 0.05% |